Dabigatran Following Transient Ischemic Attack and Minor Stroke

Trial Profile

Dabigatran Following Transient Ischemic Attack and Minor Stroke

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Apr 2018

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Aspirin
  • Indications Stroke; Transient ischaemic attacks
  • Focus Adverse reactions
  • Acronyms DATAS-II
  • Most Recent Events

    • 04 Apr 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2018.
    • 04 Apr 2018 Status changed from recruiting to active, no longer recruiting.
    • 27 Jan 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top